Podcast
This podcast is brought to you by:
Dr. Diana Brainard of AlloVir, discusses her transition into the role of a first-time CEO, the opportunities around developing allogeneic, off-the-shelf virus-specific T Cell (VST) therapy candidates, and how she kept her team motivated during COVID.
